The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Bhalla Narinder Pal since 2026.
This trader's CIK number is 2109299.
At the time of last reporting, Bhalla Narinder Pal was the Chief Medical Officer of Lexeo Therapeutics, Inc.. (stock ticker symbol LXEO).
Also see all insider trading activities at Lexeo Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | LXEO | 0 | $0 | 22,306 | $98,592 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-07-01 | LXEO | Sale | 22,306 | 4.42 | 98,592 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bhalla Narinder Pal (Chief Medical Officer of Lexeo Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.